Medical Research News

RSS

UTA research opens new doors for treatment of autoimmune diseases

Biologists at The University of Texas at Arlington have demonstrated that removing water molecules can deactivate caspase-3 enzymes, which opens new doors for treatment of autoimmune diseases like arthritis, which have been linked to overactive enzymes.

4 Oct 2016

$New review shows both types of diabetes increase risk of fragility fractures$

New review shows both types of diabetes increase risk of fragility fractures

Recent research has shown that bone health is compromised in people with diabetes, resulting in a significantly higher risk of fragility fracture.

4 Oct 2016

HDAC inhibitors show potential to eliminate breast and ovarian cancer stem cells

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).

4 Oct 2016

Hunger has stronger motivational force than fear, anxiety or thirst, study finds

Hunger is a strong motivational force, with the capacity to curb rival drives states such as thirst, anxiety, fear of predators, and social needs, according to a study in mice published September 29 in Neuron.

4 Oct 2016

Study identifies prognostic value of IDH and CIC mutations for grade II/III glioma patients

NRG Oncology investigators have identified two biomarkers that are prognostic of overall and progression-free survival for patients with lower-grade gliomas.

4 Oct 2016

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

Radiation therapy is the main treatment modality in the management of head and neck cancer.

4 Oct 2016

Researchers find better patient-reported quality of life in women who received pelvic IMRT

NRG Oncology investigators report better patient-reported quality of life measures for women who received intensity modulated radiation therapy (IMRT) for their pelvic radiation therapy (RT) than those who received standard RT.

4 Oct 2016

Women infected with Rift Valley fever virus have increased risk of miscarriages

The mosquito-borne Rift Valley fever virus has been linked to miscarriage in humans. A study of 130 pregnant Sudanese women with fever showed that the risk of miscarriage was seven times greater if the woman was infected with Rift Valley fever virus.

4 Oct 2016

Columbia researchers discover genes that may cause gum disease

Researchers at Columbia University College of Dental Medicine Columbia University Medical Center have identified 41 master regulator genes that may cause gum disease, also known as periodontal disease. The study was the first of its kind to employ genome-wide reverse engineering to identify the gene pathways that contribute to periodontitis.

4 Oct 2016

Small genetic differences linked to large effects on birth weight and poor health in later life

New research finds genetic differences that help to explain why some babies are born bigger or smaller than others.

4 Oct 2016

Children with disabilities more likely to respond aggressively when bullied, study finds

Children with disabilities--particularly those with learning disabilities, emotional disabilities and autism spectrum disorders--often are victims of bullying. However, very little research exists about how children with disabilities respond when they are bullied.

4 Oct 2016

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

A comprehensive review of studies evaluating strategies for treating certain acute medical conditions without hospital admission finds that all four evaluated strategies appear to be safe, often improve patient and caregiver satisfaction, and reduce health care costs.

4 Oct 2016

Caffeine consumption linked to reduction in risk of incident dementia in older women

Among a group of older women, self-reported caffeine consumption of more than 261 mg per day was associated with a 36 percent reduction in the risk of incident dementia over 10 years of follow-up.

4 Oct 2016

Study highlights impact of cognitive functions on oral cancer treatment

The development of oral cancer drugs as a modality therapy over the last decade has highlighted the problem of non-adherence. Only cancer drugs that are taken can actually work.

4 Oct 2016

Blocking production of key receptor may reduce effects of cigarette smoke toxicity, study finds

A Duke University-led study shows how exposure to the particulate matter from cigarette smoke may affect early development in zebrafish embryos and increases the risk of neurological disorders and physical deformities.

4 Oct 2016

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Researchers from Ben-Gurion University of the Negev have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).

4 Oct 2016

Antibody protection may help control infection caused by TB bacteria

A study led by investigators from the Ragon Institute of MGH, MIT and Harvard finds evidence that antibody protection may help control infection with the bacteria that causes tuberculosis (TB).

4 Oct 2016

New research to explore link between mixed ancestry and reduced chances of developing MND/ALS

Could the key to unlocking the secret of motor neurone disease lie in the collaboration between two small island nations, Ireland and Cuba? Researchers from Trinity College Dublin are heading to Latin America to begin a major new research project which will examine whether the likelihood of developing motor neurone disease (MND/ALS) is reduced in people with mixed ancestral backgrounds.

4 Oct 2016

Color-changing wearable sensor can inform users of total UV exposure

According to the American Cancer Society approximately 5.4 million basal and squamous cell skin cancers are diagnosed each year.

4 Oct 2016

High out-of-pocket costs may delay Medicare patients' access to novel targeted treatment for cancer

Significant out-of-pocket costs that cancer patients can face before Medicare insurance drug benefits kick in may delay the patients' treatment with a novel class of targeted therapies, according to a University of North Carolina Lineberger Comprehensive Cancer Center-led study.

4 Oct 2016

Medical Research News

UTA research opens new doors for treatment of autoimmune diseases

New review shows both types of diabetes increase risk of fragility fractures

HDAC inhibitors show potential to eliminate breast and ovarian cancer stem cells

Hunger has stronger motivational force than fear, anxiety or thirst, study finds

Study identifies prognostic value of IDH and CIC mutations for grade II/III glioma patients

IMRT linked to reduced xerostomia and feeding tube dependency in oropharyngeal cancer patients

Researchers find better patient-reported quality of life in women who received pelvic IMRT

Women infected with Rift Valley fever virus have increased risk of miscarriages

Columbia researchers discover genes that may cause gum disease

Small genetic differences linked to large effects on birth weight and poor health in later life

Children with disabilities more likely to respond aggressively when bullied, study finds

Managing low-risk acute care without hospitalization appears to be safe and reduces costs

Caffeine consumption linked to reduction in risk of incident dementia in older women

Study highlights impact of cognitive functions on oral cancer treatment

Blocking production of key receptor may reduce effects of cigarette smoke toxicity, study finds

BGU researchers elucidate molecular mechanism that could lead to new therapies for ALS

Antibody protection may help control infection caused by TB bacteria

New research to explore link between mixed ancestry and reduced chances of developing MND/ALS

Color-changing wearable sensor can inform users of total UV exposure

High out-of-pocket costs may delay Medicare patients' access to novel targeted treatment for cancer

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News